Foundation Medicine, Inc. recalls Sequencing Agent SEQ0067
- Published
- 29 Apr 2026
- Units affected
- 163 units
- Agency
- FDA
- Country
- United States
The hazard
Possible increase in phasing, potentially resulting in false-positive BARD1 splice site indel artifact variants
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.
- Check the model and lot or serial number on the device label.
- Speak to your doctor or the clinic that supplied the device before stopping use.
Product details
Sequencing Agent SEQ0067, component of FoundationOne CDx (F1CDx)
- Brand / company
- Foundation Medicine, Inc.
- Codes / lots
- Model Number: SEQ0067. Lot Numbers: 24346, 24386, 24488.
- Distribution
- US Nationwide distribution in the states of Massachusetts and North Carolina.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 29 Apr 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.